Adaptive Designs in Clinical Drug Development
26th March - 27th March 2012 | UK
Category: R&D
Address: The Grange Holborn Hotel, London, WC1B 4AR, UK
Organiser: SMi Group
Website: CLICK HERE to open.“Quote Pharmaphorum and receive £100 discount”
SMi are proud to present the 6th Annual Adaptive Designs in Clinical Drug Development conference, following on from SMi’s previous highly successful Adaptive Designs events and offers the opportunity to keep up-to-date with the latest challenges and solutions essential for successful and cost-effective adaptive clinical trials.
In recent years, the use of adaptive design in clinical trials has been considered an efficient and optimal way of designing clinical trials. Adaptive design has gradually evolved from a novel idea into a standard norm in the pharmaceutical industry. This new clinical paradigm could change the way traditional clinical trials, with their restrictive guidance, are run today.
With more flexibility, faster development timelines and significant monetary savings, an adaptive design trial is the way forward.
The conference will address adaptive clinical trials for rare disease medicine development. The agenda will not only tackle issues surrounding effective management of your adaptive design in clinical trials but the increasing use of Bayesian modelling and using adaptive designs in early clinical trials. As adaptive designs are recently gradually evolving from a novel idea into a standard norm in the pharmaceuticals industry, industry leaders are asking themselves whether to adapt or not to adapt.
Key Reasons to attend Adaptive Designs in Clinical Drug Development:
• Learn how to maximise the benefits of an adaptive design through effective management
• Develop your knowledge of the adaptive designs. From start to end, it is important to know everything about adaptive clinical trials to gain maximum advantage.
• Understand the challenges of the high-density biomarker adaptive trial.
• Discover what the future holds in this rapidly evolving market and the impact of new regulation and technology.
• Improve your clinical trials in early phases to reduce costs and time.
• Evolve your understanding of current technologies to protect trial integrity, reduce operational bias and build regulatory confidence.
• Network with key industry professionals
PLUS A HALF-DAY POST-CONFERENCE WORKSHOPS
The Bayesian Adaptive Design Process: Components, Teamwork and Simulation
28th March 2012, The Grange Holborn Hotel
8.30am – 12.45pm
Register at
http://www.smi-online.co.uk/2012adaptivedesigns11.asp
Alternatively contact Shilan Chandi on +44 (0)20 7827 6738 e-mail: schandi@smi-online.co.uk
